Analysts increase Tenet’s price target: 5 facts

Mizuho analysts increased Tenet Healthcare’s price target from $30 to $33, according to South Florida Hedge Fund Managers.

Advertisement

Here are five facts:

1. Mizuho has a “buy” rating on Tenet shares.

2. On March 16, Tenet shares opened at $28.14.

3. The company has a 50-day moving average of $25.72 and 200-day moving average of $31.84.

4. Tenet’s 12-month high is $60.93 and 12-month low is $21.39.

5. The market cap is $2.77 billion.

More articles on surgery centers:
ASC of Western New York achieves approval to move forward with $4.75M ASC: 5 key notes
5 points on Surgery Partners proposed $400M senior notes offering
Medical Facilities Corp. revenue hits $90M in Q4 — 6 takeaways

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.